Usage of long-acting muscarinic antagonists and biologics as add-on therapy for patients in the United States with moderate-to-severe asthma.

C Victor Spain  ¹ , Parul Dayal  ¹ , Yingjie Ding  ² , Carlos Iribarren  ³ , Theodore A Omachi  ¹ , Hubert Chen  ¹

来源出处

Usage of long-acting muscarinic antagonists and biologics as add-on therapy for… https://pubmed.ncbi.nlm.nih.gov/33970741